[Neutrophilic eccrine hidradenitis associated with relapse of acute myeloblastic leukemia]. 1998

V Saada, and S Aractingi, and V Leblond, and E Marinho, and C Frances, and O Chosidow
Unité de Dermatologie, Hõpital Tenon.

BACKGROUND Neutrophilic eccrine hidradentitis is a recently described clinical entity. Most reported cases have occurred in patients given chemotherapy for acute myelogenous leukemia, suggesting a drug induced mechanism. Some authors have considered however that neutrophilic eccrine hidradenitis belongs to the group of neutrophilic dermatoses. METHODS We observed neutrophilic eccrine hidradentitis in a 48-year-old man which developed when he suffered a relapse of acute leukemia. He had not been given chemotherapy in the preceding months. CONCLUSIONS This case favors the hypothesis that neutrophilic eccrine hidradenitis is associated with myeloid hemotology disorders and not a complications secondary to treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute
D016575 Hidradenitis The inflammation of a sweat gland (usually of the apocrine type). The condition can be idiopathic or occur as a result of or in association with another underlying condition. Neutrophilic eccrine hidradenitis is a relatively rare variant that has been reported in patients undergoing chemotherapy, usually for non-Hodgkin lymphomas or leukemic conditions. Hidrosadenitis,Neutrophilic Eccrine Hidradenitis,Hydradenitis,Eccrine Hidradenitides, Neutrophilic,Eccrine Hidradenitis, Neutrophilic,Hidradenitides,Hidradenitides, Neutrophilic Eccrine,Hidradenitis, Neutrophilic Eccrine,Hidrosadenitides,Hydradenitides,Neutrophilic Eccrine Hidradenitides

Related Publications

V Saada, and S Aractingi, and V Leblond, and E Marinho, and C Frances, and O Chosidow
June 2015, Presse medicale (Paris, France : 1983),
V Saada, and S Aractingi, and V Leblond, and E Marinho, and C Frances, and O Chosidow
January 1987, The American journal of pediatric hematology/oncology,
V Saada, and S Aractingi, and V Leblond, and E Marinho, and C Frances, and O Chosidow
January 1996, Anales de medicina interna (Madrid, Spain : 1984),
V Saada, and S Aractingi, and V Leblond, and E Marinho, and C Frances, and O Chosidow
January 2014, The Pan African medical journal,
V Saada, and S Aractingi, and V Leblond, and E Marinho, and C Frances, and O Chosidow
May 2010, Leukemia research,
V Saada, and S Aractingi, and V Leblond, and E Marinho, and C Frances, and O Chosidow
October 1984, Journal of the American Academy of Dermatology,
V Saada, and S Aractingi, and V Leblond, and E Marinho, and C Frances, and O Chosidow
January 1992, Acta haematologica,
V Saada, and S Aractingi, and V Leblond, and E Marinho, and C Frances, and O Chosidow
January 1988, Medical and pediatric oncology,
V Saada, and S Aractingi, and V Leblond, and E Marinho, and C Frances, and O Chosidow
December 2022, American journal of hematology,
V Saada, and S Aractingi, and V Leblond, and E Marinho, and C Frances, and O Chosidow
June 1993, Archives of dermatology,
Copied contents to your clipboard!